![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 2, 858-866, January 13, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*




1
2
From the
Division of Cellular Biochemistry, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands and
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112
The retinoblastoma protein (pRB) is a tumor suppressor and key regulator of the cell cycle. We have previously shown that pRB interacts with phosphatidylinositol-4-phosphate 5-kinases, lipid kinases that can regulate phosphatidylinositol 4,5-bisphosphate levels in the nucleus. Here, we investigated pRB binding to another lipid kinase in the phosphoinositide cycle, diacylglycerol kinase (DGK) that phosphorylates the second messenger diacylglycerol to yield phosphatidic acid. We found that DGK
, but not DGK
or DGK
, interacts with pRB in vitro and in vivo. Binding of DGK
to pRB is dependent on the phosphorylation status of pRB, since only hypophosphorylated pRB interacts with DGK
. DGK
also binds to the pRB-related pocket proteins p107 and p130 in vitro and in cells. Although DGK
did not affect the ability of pRB to regulate E2F-mediated transcription, we found that pRB, p107, and p130 potently stimulate DGK
activity in vitro. Finally, overexpression of DGK
in pRB-null fibroblasts reconstitutes a cell cycle arrest induced by
-irradiation. These results suggest that DGK
may act in vivo as a downstream effector of pRB to regulate nuclear levels of diacylglycerol and phosphatidic acid.
Received for publication, March 11, 2005 , and in revised form, November 4, 2005.
* This work was supported by Dutch Cancer Society Grant NKI 2000-2209. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence may be addressed. Fax: 31-205121989; E-mail: w.v.blitterswijk{at}nki.nl. 2To whom correspondence may be addressed. Fax: 31-205121989; E-mail: n.divecha{at}nki.nl.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Guo, C.-K. Wan, J. H. Carpenter, T. Mousallem, R.-M. N. Boustany, C.-T. Kuan, A. W. Burks, and X.-P. Zhong Synergistic control of T cell development and tumor suppression by diacylglycerol kinase {alpha} and {zeta} PNAS, August 19, 2008; 105(33): 11909 - 11914. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, A. N. Urs, J. Allegood, A. Leon, A. H. Merrill Jr., and M. B. Sewer Cyclic AMP-Stimulated Interaction between Steroidogenic Factor 1 and Diacylglycerol Kinase {theta} Facilitates Induction of CYP17 Mol. Cell. Biol., October 1, 2007; 27(19): 6669 - 6685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Evangelisti, P. L. Tazzari, M. Riccio, R. Fiume, Y. Hozumi, F. Fala, K. Goto, L. Manzoli, L. Cocco, and A. M. Martelli Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts FASEB J, October 1, 2007; 21(12): 3297 - 3307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |